Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trans fat reg

This article was originally published in The Tan Sheet

Executive Summary

FDA rule requiring disclosure of trans fat on nutrition labeling slated for FY 2003 completion, agency says following July 10 release of Institute of Medicine report on the substance. IOM panel finds "positive linear trend between trans fatty acid intake and total and LDL cholesterol concentration, and therefore increased risk" of coronary heart disease, "thus suggesting an [upper limit] of zero." However, achieving the suggested UL "would require extraordinary changes in patterns of dietary intake," IOM acknowledges. Consequently, report proposes no UL but recommends trans fat consumption "be as low as possible while consuming a nutritionally adequate diet"...

Related Content

Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts